These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23898841)

  • 61. Identification of Phenoxyalkylbenzimidazoles with Antitubercular Activity.
    Chandrasekera NS; Alling T; Bailey MA; Files M; Early JV; Ollinger J; Ovechkina Y; Masquelin T; Desai PV; Cramer JW; Hipskind PA; Odingo JO; Parish T
    J Med Chem; 2015 Sep; 58(18):7273-85. PubMed ID: 26295286
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis.
    Mak PA; Rao SP; Ping Tan M; Lin X; Chyba J; Tay J; Ng SH; Tan BH; Cherian J; Duraiswamy J; Bifani P; Lim V; Lee BH; Ling Ma N; Beer D; Thayalan P; Kuhen K; Chatterjee A; Supek F; Glynne R; Zheng J; Boshoff HI; Barry CE; Dick T; Pethe K; Camacho LR
    ACS Chem Biol; 2012 Jul; 7(7):1190-7. PubMed ID: 22500615
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Activity of Moxifloxacin against
    Louie A; Duncanson B; Myrick J; Maynard M; Nole J; Brown D; Schmidt S; Neely M; Scanga CA; Peloquin C; Drusano GL
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249693
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Yeast three-hybrid screening for identifying anti-tuberculosis drug targets.
    Moser S; Johnsson K
    Chembiochem; 2013 Nov; 14(17):2239-42. PubMed ID: 24133019
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Benzimidazole-based compounds kill Mycobacterium tuberculosis.
    Gong Y; Somersan Karakaya S; Guo X; Zheng P; Gold B; Ma Y; Little D; Roberts J; Warrier T; Jiang X; Pingle M; Nathan CF; Liu G
    Eur J Med Chem; 2014 Mar; 75():336-53. PubMed ID: 24556148
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Analysis and hit filtering of a very large library of compounds screened against Mycobacterium tuberculosis.
    Ekins S; Kaneko T; Lipinski CA; Bradford J; Dole K; Spektor A; Gregory K; Blondeau D; Ernst S; Yang J; Goncharoff N; Hohman MM; Bunin BA
    Mol Biosyst; 2010 Nov; 6(11):2316-2324. PubMed ID: 20835433
    [TBL] [Abstract][Full Text] [Related]  

  • 67. QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity.
    Gomes MN; Braga RC; Grzelak EM; Neves BJ; Muratov E; Ma R; Klein LL; Cho S; Oliveira GR; Franzblau SG; Andrade CH
    Eur J Med Chem; 2017 Sep; 137():126-138. PubMed ID: 28582669
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan ŞD; Gündüz MG; Doğan H; Krishna VS; Lherbet C; Sriram D
    Eur J Med Chem; 2020 Aug; 199():112402. PubMed ID: 32417538
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Large-scale chemical-genetics yields new M. tuberculosis inhibitor classes.
    Johnson EO; LaVerriere E; Office E; Stanley M; Meyer E; Kawate T; Gomez JE; Audette RE; Bandyopadhyay N; Betancourt N; Delano K; Da Silva I; Davis J; Gallo C; Gardner M; Golas AJ; Guinn KM; Kennedy S; Korn R; McConnell JA; Moss CE; Murphy KC; Nietupski RM; Papavinasasundaram KG; Pinkham JT; Pino PA; Proulx MK; Ruecker N; Song N; Thompson M; Trujillo C; Wakabayashi S; Wallach JB; Watson C; Ioerger TR; Lander ES; Hubbard BK; Serrano-Wu MH; Ehrt S; Fitzgerald M; Rubin EJ; Sassetti CM; Schnappinger D; Hung DT
    Nature; 2019 Jul; 571(7763):72-78. PubMed ID: 31217586
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Discovery of selective menaquinone biosynthesis inhibitors against Mycobacterium tuberculosis.
    Debnath J; Siricilla S; Wan B; Crick DC; Lenaerts AJ; Franzblau SG; Kurosu M
    J Med Chem; 2012 Apr; 55(8):3739-55. PubMed ID: 22449052
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery.
    Christophe T; Ewann F; Jeon HK; Cechetto J; Brodin P
    Future Med Chem; 2010 Aug; 2(8):1283-93. PubMed ID: 21426019
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
    Cai G; Napolitano JG; McAlpine JB; Wang Y; Jaki BU; Suh JW; Yang SH; Lee IA; Franzblau SG; Pauli GF; Cho S
    J Nat Prod; 2013 Nov; 76(11):2009-18. PubMed ID: 24224794
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combinations of Respiratory Chain Inhibitors Have Enhanced Bactericidal Activity against Mycobacterium tuberculosis.
    Berube BJ; Parish T
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061760
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis.
    Li W; Upadhyay A; Fontes FL; North EJ; Wang Y; Crans DC; Grzegorzewicz AE; Jones V; Franzblau SG; Lee RE; Crick DC; Jackson M
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6413-23. PubMed ID: 25136022
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dual Inhibition of
    Nandakumar M; Ollodart A; Fleck N; Kapadia NR; Frando A; Boradia V; Smith JL; Chen J; Zuercher WJ; Willson TM; Grundner C
    J Med Chem; 2023 Nov; 66(21):14724-14734. PubMed ID: 37871287
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?
    Goldman RC
    Tuberculosis (Edinb); 2013 Nov; 93(6):569-88. PubMed ID: 24119636
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Expanding Diversity of Mycobacterium tuberculosis Drug Targets.
    Wellington S; Hung DT
    ACS Infect Dis; 2018 May; 4(5):696-714. PubMed ID: 29412643
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dual-Pharmacophore Pyrithione-Containing Cephalosporins Kill Both Replicating and Nonreplicating
    Lopez Quezada L; Li K; McDonald SL; Nguyen Q; Perkowski AJ; Pharr CW; Gold B; Roberts J; McAulay K; Saito K; Somersan Karakaya S; Javidnia PE; Porras de Francisco E; Amieva MM; Dı Az SP; Mendoza Losana A; Zimmerman M; Liang HH; Zhang J; Dartois V; Sans S; Lagrange S; Goullieux L; Roubert C; Nathan C; Aubé J
    ACS Infect Dis; 2019 Aug; 5(8):1433-1445. PubMed ID: 31184461
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis.
    Vocat A; Hartkoorn RC; Lechartier B; Zhang M; Dhar N; Cole ST; Sala C
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4012-9. PubMed ID: 25896710
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 8-Hydroxyquinolines Are Boosting Agents of Copper-Related Toxicity in Mycobacterium tuberculosis.
    Shah S; Dalecki AG; Malalasekera AP; Crawford CL; Michalek SM; Kutsch O; Sun J; Bossmann SH; Wolschendorf F
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5765-76. PubMed ID: 27431227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.